Ionis Pharmaceuticals, Inc.
IONS
$75.83
$0.450.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 59.66% | -78.37% | -204.09% | 184.08% | -40.81% |
| Total Depreciation and Amortization | 1.44% | 63.06% | -17.46% | 1.06% | 2.47% |
| Total Amortization of Deferred Charges | 19.36% | 19.13% | 0.36% | 0.24% | -1.91% |
| Total Other Non-Cash Items | -65.76% | 1,738.30% | -107.26% | 62.28% | -28.97% |
| Change in Net Operating Assets | -3,160.55% | 540.72% | 81.00% | 30.82% | 32.92% |
| Cash from Operations | -475.72% | -4.77% | -186.85% | 200.37% | -29.82% |
| Capital Expenditure | -2.21% | -304.02% | 57.17% | 2.16% | 50.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 240.27% | -512.19% | 189.65% | -158.88% | 95.32% |
| Cash from Investing | 227.97% | -559.29% | 176.07% | -170.44% | 149.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.98% | -652,807.32% | -2.50% | 4.76% | 99.91% |
| Issuance of Common Stock | -46.85% | 32.68% | 6,213.83% | -42.57% | 422.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.31% | 627.89% | 6,413.07% | -43.29% | 104.98% |
| Foreign Exchange rate Adjustments | -220.93% | 47.56% | -113.78% | 156.47% | 147.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -686.34% | -17.35% | 23.93% | 49.73% | 123.90% |